Nye og genopdagede medikamenter til behandling af tuberkulose
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Nye og genopdagede medikamenter til behandling af tuberkulose. / Kraef, Christian; Lillebæk, Troels; Andersen, Åse Bengård; Kirk, Ole.
I: Ugeskrift for Laeger, Bind 184, Nr. 10, V10210783, 2022.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nye og genopdagede medikamenter til behandling af tuberkulose
AU - Kraef, Christian
AU - Lillebæk, Troels
AU - Andersen, Åse Bengård
AU - Kirk, Ole
PY - 2022
Y1 - 2022
N2 - Tuberculosis (TB) is still a major challenge for global health, but in recent years there have been several important developments in treatment options. Shorter treatment regimens for latent TB, based on conventional drugs, offer better adherence and fewer side effects, while new and repurposed antibiotics have opened the door to more effective, shorter and less side effect-heavy treatments for drug susceptible TB and multidrug-resistant/extensively drug resistant TB as well as atypical mycobacterioses. This review investigates how these shorter and predominantly oral treatments, in the future, are expected to be used in combination with individualized precision medicine.
AB - Tuberculosis (TB) is still a major challenge for global health, but in recent years there have been several important developments in treatment options. Shorter treatment regimens for latent TB, based on conventional drugs, offer better adherence and fewer side effects, while new and repurposed antibiotics have opened the door to more effective, shorter and less side effect-heavy treatments for drug susceptible TB and multidrug-resistant/extensively drug resistant TB as well as atypical mycobacterioses. This review investigates how these shorter and predominantly oral treatments, in the future, are expected to be used in combination with individualized precision medicine.
M3 - Tidsskriftartikel
C2 - 35315752
VL - 184
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 10
M1 - V10210783
ER -
ID: 301455279